Sotatercept for treating pulmonary arterial hypertension [ID6163]

  • In development
  • GID-TA11103
  • Expected publication date: TBC

NICE has paused the evaluation of sotatercept for treating pulmonary arterial hypertension [ID6163] because the company and NHSE have commenced commercial discussions.

Please note that following a call between NICE and the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin during early June 2024 when we will write to you about how you can get involved.